Current issues in Wilms tumor management Journal Article


Authors: Grundy, P.; Perlman, E.; Rosen, N. S.; Warwick, A. B.; Bender, J. G.; Ehrlich, P.; Hoffer, F. A.; Lee, N. D.
Article Title: Current issues in Wilms tumor management
Keywords: immunohistochemistry; vasculotropin; cancer chemotherapy; cancer survival; protein expression; mutation; histone deacetylase inhibitor; lenalidomide; clinical trial; review; bevacizumab; doxorubicin; erlotinib; hypertension; cancer radiotherapy; radiation dose; temozolomide; topotecan; cancer staging; nuclear magnetic resonance imaging; cancer diagnosis; polymerase chain reaction; diagnostic procedure; carboplatin; apoptosis; computer assisted tomography; nephrotoxicity; etoposide; bleeding; blood toxicity; differential diagnosis; cyclophosphamide; vincristine; deep vein thrombosis; biopsy; histology; ifosfamide; risk assessment; irinotecan; injection site reaction; confidence interval; survival time; lung metastasis; tipifarnib; dactinomycin; outcomes research; imaging; radiography; 5 aza 2' deoxycytidine; drug half life; dna topoisomerase inhibitor; toxicity; oxaliplatin; epistaxis; pemetrexed; antiangiogenic activity; oblimersen; congestive heart failure; proteinuria; nephroblastoma; depsipeptide
Journal Title: Current Problems in Cancer
Volume: 29
Issue: 5
ISSN: 0147-0272
Publisher: Mosby Elsevier  
Date Published: 2005-09-01
Start Page: 223
End Page: 260
Language: English
DOI: 10.1016/j.currproblcancer.2005.08.002
PROVIDER: scopus
PUBMED: 16216623
DOI/URL:
Notes: --- - "Export Date: 4 June 2012" - "CODEN: CPRCD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nancy S Rosen
    28 Rosen